| [1] | PRICE M, NEFF C, NAGARAJAN N, et al. CBTRUS statistical report: American brain tumor association & NCI neuro-oncology branch adolescent and young adult primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020[J]. Neuro Oncol, 2024, 26(Supplement_3): iii1-iii53. doi: 10.1093/neuonc/noae047 |
| [2] | WELLER M, VAN DEN BENT M, PREUSSER M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood[J]. Nat Rev Clin Oncol, 2021, 18(3): 170-186. doi: 10.1038/s41571-020-00447-z |
| [3] | YANG B W, DING L, CHEN Y, et al. Augmenting tumor-starvation therapy by cancer cell autophagy inhibition[J]. Adv Sci, 2020, 7(6): 1902847. doi: 10.1002/advs.201902847 |
| [4] | SUN P, MA L N, LU Z M. Lactylation: Linking the Warburg effect to DNA damage repair[J]. Cell Metab, 2024, 36(8): 1637-1639. doi: 10.1016/j.cmet.2024.06.015 |
| [5] | TANG Y, JI Y J, YI C L, et al. Self-accelerating H2O2-responsive plasmonic nanovesicles for synergistic chemo/starving therapy of tumors[J]. Theranostics, 2020, 10(19): 8691-8704. doi: 10.7150/thno.45392 |
| [6] | CHANDER S, KULKARNI G T, DHIMAN N, et al. Protein-based nanohydrogels for bioactive delivery[J]. Front Chem, 2021, 9: 573748. doi: 10.3389/fchem.2021.573748 |
| [7] | GAO J, ZHAI Y H, LU W H, et al. ROS-sensitive PD-L1 siRNA cationic selenide nanogels for self-inhibition of autophagy and prevention of immune escape[J]. Bioact Mater, 2024, 41: 597-610. doi: 10.1016/j.bioactmat.2024.08.013 |
| [8] | CUGGINO J C, BLANCO E R O, GUGLIOTTA L M, et al. Crossing biological barriers with nanogels to improve drug delivery performance[J]. J Control Release, 2019, 307: 221-246. doi: 10.1016/j.jconrel.2019.06.005 |
| [9] | LIMITI E, MOZETIC P, GIANNITELLI S M, et al. Hyaluronic acid–polyethyleneimine nanogels for controlled drug delivery in cancer treatment[J]. ACS Appl Nano Mater, 2022, 5(4): 5544-5557. doi: 10.1021/acsanm.2c00524 |
| [10] | YANG C C, LI C, ZHANG P, et al. Redox responsive hyaluronic acid nanogels for treating RHAMM(CD168)over-expressive cancer, both primary and metastatic tumors[J]. Theranostics, 2017, 7(6): 1719-1734. doi: 10.7150/thno.18340 |
| [11] | WANG X, WANG Q G. Enzyme-laden bioactive hydrogel for biocatalytic monitoring and regulation[J]. Acc Chem Res, 2021, 54(5): 1274-1287. doi: 10.1021/acs.accounts.0c00832 |